homehome Home chatchat Notifications


Scientists reverse leading cause of late-onset Alzheimer's, opening door for vaccine that prevents the disease

This could lead to a game-changing therapy.

Tibi Puiu
December 19, 2018 @ 3:41 pm

share Share

Credit: Pixabay.

A team of researchers at the University of Texas Southwestern Medical Center may have found a way to prevent Alzheimer’s disease from clogging brain tissue. Their novel approach could be turned into a drug or vaccine that would prevent the debilitating disease in 50 to 80% of at-risk adults.

Alzheimer’s is the leading cause of dementia. The neurodegenerative disease affects cognitive and thinking abilities, making day-to-day life incredibly challenging in its most advanced stages.

After a certain age, the human brain starts to shrink considerably but surprisingly, not too many neurons die in the process. In the Alzheimer’s diseased brain, however, many neurons stop functioning, lose connections with other neurons, and eventually die.

In the early stage, the damage is confined to the entorhinal cortex and hippocampus, two areas associated with memory, navigation, and perception of time. This sort of degeneration leads to memory loss and disorientation associated with the condition — though it has to be noted that Alzheimer’s starts damaging brain cells well even before the first symptoms kick in.

Later on, the disease starts to hit the cerebral cortex responsible for language, reasoning, and social behavior, from where it eventually spreads to other brain areas.

Research has shown that individuals with Alzheimer’s disease accumulate beta-amyloid proteins which clump together to form plaques between neurons and disrupt cell function. Another physical characteristic of the Alzheimer’s diseased brain is the buildup of tau proteins. which tangle inside neurons blocking the cells’ transport system.

Currently, there is no available cure for Alzheimer’s disease. Most research efforts are focused on findings ways to halt the progress of the disease and reduce its symptoms. However, molecular biologist Joachim Herz and colleagues at UT Southwestern have embarked on a different route: instead of looking for ways to stop the spread of amyloid and tau accumulation when the process has already set in, the researchers are looking to prevent the buildup from happening in the first place. In other words, they want to prevent the disease rather than treat it.

There are three major forms of Apolipoprotein E (ApoE) proteins that play a vital role in the brain tissue repair by carrying lipids and cholesterol around the brain. However, individuals who carry ApoE4 are up to 10 times more likely to get Alzheimer’s than those with the ApoE2 and ApoE3 forms.

Herz and colleagues claim that ApoE4 causes “traffic jams” inside neuron cells, thereby leading to inefficient recycling of intracellular endosomal transport vesicles. Their research on mice found that lowering the pH of these endosomes (making them more acidic) cleared the traffic jams. Specifically, the ApoE4-induced blockages were reversed by inhibiting the NHE6 protein, which is responsible for making endosomal vesicles less acidic.

“Our approach in this study was to stop the overall degeneration process earlier; that is, before the formation of these aggregates [i.e. amyloid and tau protein],” Dr. Herz said in a statement.

The findings provide a new therapeutic pathway that could prevent Alzheimer’s in 50% to 80% of at-risk adults. A vaccine or drug that selectively blocks NHE6 could be administered before age 40, providing a lifetime of Alzheimer’s protection. Developing such tailor-made molecules is the next step for the UT Southwestern researchers.

“The beauty of NHE inhibitors is that these are small molecules that can be produced inexpensively and thus made widely available, in contrast to the more elaborate antibody-based therapies that are currently being evaluated in clinical trials. A simple pill could someday neutralize the risk of late-onset Alzheimer’s disease just as readily available statins are able to reduce the risk of cardiovascular disease,” Dr. Herz said.

The findings were reported in the journal eLife.

share Share

A Simple Heat Hack Could Revolutionize How We Produce Yogurt

In principle, the method could be deployed tomorrow, researchers say.

Scientists Create a ‘Smart Sponge’ That Knows When to Heal and When to Fight Inflammation

This hydrogel could help millions of people lead a better life.

The Race to the Bottom: Japan Is Set to Start Testing Deep-Sea Mining

There's a big hidden cost to this practice.

Japan Just Smashed the Internet Speed World Record and It's Much Faster Than You Think

Researchers transmitted 127,500 GB every second — over the distance from Chicago to Dallas.

Can You Tell Which Knot Is Strongest? Most People Fail This Surprisingly Tough Challenge

Knots are a test of physical intuition and most of us are failing hard.

Scientists Call for a Global Pause on Creating “Mirror Life” Before It’s Too Late: “The threat we’re talking about is unprecedented”

Creating synthetic lifeforms is almost here, and the consequences could be devastating.

For the First Time Ever We Can See Planets Starting to Form Around a Star

JWST and ALMA peered through a natural opening in the star’s surrounding cloud to catch the action up close.

Low testosterone isn't killing your libido. Sugar is

Small increases in blood sugar can affect sperm and sex, even without diabetes

There might be an anti-aging secret hiding in magic mushrooms

Psilocybin extends cell life, and preserves aging DNA structures.

Not Just Hunters: Wooden Tools Unearth the Sophisticated, Plant-Eating World of Early Humans

What if the Stone Age wasn't really about stone?